The C-peptide test, a pivotal diagnostic tool, distinguishes between type 1 and type 2 diabetes, crucial for Hypro Diagnostics. In cases of type 1, where the immune system attacks pancreatic cells, or type 2, marked by inefficient insulin use, this test plays a key role. It assesses insulin production, essential for glucose transfer from blood to cells. Such insights guide tailored interventions, aiding Hypro Diagnostics in determining optimal treatments, including the potential use of insulin for effective condition management.
Reviews
There are no reviews yet.